Insider filing · ZBIO
Peter Evan Harwin
Director
profile →
Zenas BioPharma, Inc.
ZBIO · Healthcare · 18 filings in 24 months
ticker →
Peter Evan Harwin bought $5.1M of Zenas BioPharma (ZBIO)
Executed Sep 16 2024, disclosed Sep 16 2024, the same day.
Value, as filed
$5.1M
300,000 sh × $17.00
Executed
Sep 16 2024
the trade date, as filed
Disclosed
Sep 16 2024
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
+4.9%
+4.9% from execution
Over the 21 trading sessions from the disclosed entry session (Sep 16 2024), the stock returned +4.9% (delay-adjusted); from the execution session (Sep 16 2024), +4.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
The filer
PHPeter Evan Harwin (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $133.5M of APGE (1,750,000 sh × $76.30, as filed), executed Jan 22.
The name
ZBIOHealthcare · Zenas BioPharma, Inc., a clinical-stage biopharma company, engages in the development and commercialization of transformative immunology-ba…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→